Checkpoint Therapeutics's market cap is currently ―. The company's EPS TTM is $-5.185; its P/E ratio is -0.37; Checkpoint Therapeutics is scheduled to report earnings on November 8, 2023, and the estimated EPS forecast is $-0.74. See an overview of income statement, balance sheet, and cash flow financials.

	Jun 23	Mar 23	Dec 22	Sep 22	Jun 22
Income Statement	-
Total Revenue	$ 31.00K	$ 35.00K	$ 74.00K	$ 48.00K	$ 18.00K
Gross Profit	$ 31.00K	$ 35.00K	$ 74.00K	-	-
EBIT	$ -16.52M	$ -10.47M	$ -16.64M	$ -10.66M	$ -14.16M
EBITDA	$ -16.52M	$ -10.47M	$ -16.64M	$ -10.66M	$ -14.16M
Net Income Common Stockholders	$ -16.52M	$ -10.47M	$ -21.02M	$ -10.61M	$ -14.14M
Balance Sheet	-
Cash, Cash Equivalents and Short-Term Investments	$ 7.42M	$ 4.85M	$ 12.07M	$ 20.48M	$ 30.89M
Total Assets	$ 8.34M	$ 5.90M	$ 13.29M	$ 21.62M	$ 32.08M
Total Debt	$ 0.00	$ 0.00	$ 0.00	$ 0.00	$ 0.00
Net Debt	$ -7.42M	$ -4.85M	$ -12.07M	$ -20.48M	$ -30.89M
Total Liabilities	$ 27.65M	$ 24.47M	$ 32.77M	$ 22.95M	$ 24.62M
Stockholders Equity	$ -19.31M	$ -18.57M	$ -19.48M	$ -1.33M	$ 7.46M
Cash Flow	-
Free Cash Flow	$ -11.98M	$ -14.03M	$ -15.30M	$ -11.42M	$ -11.23M
Operating Cash Flow	$ -11.98M	$ -14.03M	$ -15.30M	$ -11.42M	$ -11.23M
Investing Cash Flow	-	-	-	-	-
Financing Cash Flow	$ 14.55M	$ 6.81M	$ 6.89M	$ 1.01M	$ 642.00K

Currency in USD

Checkpoint Therapeutics Earnings and Revenue History

Income Statement >

Checkpoint Therapeutics Debt to Assets

Balance Sheet >

Checkpoint Therapeutics Cash Flow

Cash Flow >

Checkpoint Therapeutics Forecast EPS vs Actual EPS

Earnings >

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing